Retro virus-elicited interleukin-12 and tumour necrosis factor-α as inducers of interferon-γ-mediated pathology in mouse AIDS

Immunology

Volumn 87, Issue 3, 1996, Pages 467-474

  Giese, N A ^a,e   Gazzinelli, R T ^a,c   Actor, J K ^a,d   Morawetz, R A ^a   Sarzotti, M ^b   Morse III, H C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d Vetlife Inc   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SPLEEN CELL;

ANIMALS; FEMALE; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; POLYMERASE CHAIN REACTION; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029936753     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.492569.x     Document Type: Article

References (31)

1. MORSE H.C. III, CHATTOPADHYAY S.K., MAKINO M., FREDRICKSON T.N., HÜGIN A.W. & HARTLEY J.W. (1992) Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 6, 607.
2. JOLICOEUR P. (1991) Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis. FASEB J 5, 2398.
3. MORSE H.C. III, GIESE N., MORAWETZ R. et al. (1995) Cells and cytokines in the pathogenesis of MAIDS, a retrovirus-induced immunodeficiency syndrome of mice. Springer Sem Immunopathol 17, 231.
4. GAZZINELLI R.T., GIESE N.A. & MORSE H.C. III. (1994) In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J Exp Med 180, 2199.
5. WANG Y., ARDESTANI S.K., LIANG B., BECKHAM C. & WATSON R.R. (1994) Anti-IL-4 monoclonal antibody and IFN-γ administration retards development of immune dysfunction and cytokine dysregulation during murine AIDS. Immunology 83, 384.
6. UEHARA S., HITOSHI Y., NUMATA F. et al. (1994) An IFN-γ-dependent pathway plays a critical role in the pathogenesis of murine immunodeficiency syndrome induced by LP-BM5 murine leukemia virus. Int Immunol 6, 1937.
7. DALTON D.K., PITTS-MEEK S., KESHAV S., FIGARI I.S., BRADLEY A. & STEWART T.A. (1993) Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259, 1739.
8. CHATTOPADHYAY S.K., MORSE H.C. III, MAKINO M., RUSCETTI S.K. & HARTLEY J.W. (1989) Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome. Proc Natl Acad Sci USA 86, 3862.
9. HARTLEY J.W., FREDRICKSON T.N., YETTER R.A., MAKINO M. & MORSE H.C. III. (1989) Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J Virol 63, 1223.
10. ROWE W.P., PUGH W.E. & HARTLEY J.W. (1970) Plaque assay techniques for murine leukemia viruses. Virology 42, 1136.
11. CLOYD M.W., HARTLEY J.W. & ROWE W.P. (1980) Lymphoma-genicity of recombinant mink cell focus-inducing murine leukemia viruses. J Exp Med 151, 542.
12. SCHOENHAUT D.S., CHUA A.O., WOLITZKY A.G. et al. (1992) Cloning and expression of murine IL-12. J Immunol 148, 3433.
13. MOSMANN T. & FONG T.A.T. (1989) Specific assays for cytokine production by T cells. J Immunol Meth 116, 151.
14. SVETIC A., FINKELMAN F.D., JIAN Y.C. et al. (1991) Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol 147, 2391.
15. GAZZINELLI R.T., ELTOUM I., WYNN T.A. & SHER A. (1993) Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J Immunol 151, 3672.
16. GAZZINELLI R.T., HIENY S., WYNN T.A., WOLF S. & SHER A. (1993) Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 90, 6115.
17. PITHA P.M., BIEGEL D., YETTER R.A. & MORSE H.C. III. (1988) Abnormal regulation of IFN-α, -β, and -γ expression in MAIDS, a murine retrovirus-induced immunodeficiency syndrome. J Immunol 141, 3611.
18. CHEUNG S.C., CHATTOPADHYAY S.K., MORSE H.C. III & Pitha P.M. (1991) Expression of defective virus and cytokine genes in murine AIDS. J Virol 65, 823.
19. MAKINO M., WINKLER D.F., WUNDERLICH J., HARTLEY J.W., MORSE H.C. III & HOLMES K.L. (1993) High expression of NK-1.1 antigen is induced by infection with murine AIDS virus. Immunology 80, 319.
20. + subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol 148, 182.
21. MURALIDHAR G., KOCH S., HAAS M. & SWAIN S.L. (1992) CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy. J Exp Med 175, 1589.
22. TRIPP C.S., WOLF S.F. & UNANUE E.R. (1993) Interleukin 12 and tumor necrosis factor a are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 90, 3725.
23. MAKINO M., MORSE H.C. III, FREDRICKSON T.N. & HARTLEY J.W. (1990) H-2-associated and background genes influence the development of a murine retrovirus-induced immunodeficiency syndrome. J Immunol 144, 4347.
24. MORAWETZ R.A., DOHERTY T.M., GIESE N.A. et al. (1994) Resistance to murine acquired immunodeficiency syndrome (MAIDS). Science 265, 264.
25. ISHIDA H., HASTINGS R., KEARNEY J. & HOWARD M. (1992) Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med 175, 1213.
26. KÜHN R., LÖHLER J., RENNICK D., RAJEWSKV K. & MÜLLER W. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263.
27. SCHALL T.J., O'HEHIR R.E., GOEDDEL D.V. & LAMB J.R. (1992) Uncoupling of cytokine mRNA expression and protein secretion during the induction phase of T cell anergy. J Immunol 148, 381.
28. GAZZINELLI R.T., HARTLEY J.W., FREDRICKSON T.N., CHATTOPADHYAY S.K., SHER A. & MORSE H.C. III. (1992) Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses. Infect Immun 60, 4394.
29. HUGIN A.W., CERNY A. & MORSE H.C. III. (1994) Mice with an acquired immunodeficiency (MAIDS) develop a persistent infection after injection with Listeria monocytogenes. Cell Immunol 155, 246.
30. BARRAL-NETTO M., DASILVA J.S., BARRAL A. & REED S. (1995) Upregulation of T helper 2 and down-regulation of T helper 1 cytokines during murine retrovirus-induced immunodeficiency syndrome enhances susceptibility of a resistant mouse strain to Leishmania amazonensis. Am J Pathol 146, 635.
31. DOHERTY T.M., MORSE H.C. III & COFFMAN R.L. (1994) Modulation of specific T cell responses by concurrent infection with Leishmania major and LP-BM5 murine leukemia viruses. Int Immunol 7, 131.